Use of Web-based training for quality improvement between a field immunohistochemistry laboratory in Nigeria and its United States-based partner institution

Annals of Diagnostic Pathology

Volumn 17, Issue 6, 2013, Pages 526-530

  Oluwasola, Abideen O ^a   Malaka, David ^b   Khramtsov, Andrey Ilyich ^b   Ikpatt, Offiong Francis ^c   Odetunde, Abayomi ^d   Adeyanju, Oyinlolu Olorunsogo ^e   Sveen, Walmy Elisabeth ^b   Falusi, Adeyinka Gloria ^d   Huo, Dezheng ^b   Olopade, Olufunmilayo Ibironke ^b  

^a UNIVERSITY OF IBADAN   (Nigeria)

^b UNIVERSITY OF CHICAGO   (United States)

^c UNIVERSITY OF MIAMI   (United States)

^d UNIVERSITY OF IBADAN   (Nigeria)

^e NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Immunohistochemistry; Quality improvement; Tissue microarray; Web based conferences

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; ERBB2 PROTEIN, HUMAN; TUMOR MARKER;

ARTICLE; BREAST CANCER; COMPARATIVE STUDY; COMPUTER PROGRAM; CONSULTATION; DIAGNOSTIC ACCURACY; IMMUNOHISTOCHEMISTRY; INTERNET; LABORATORY; MEDICAL EDUCATION; NIGERIA; PRIORITY JOURNAL; QUALITY CONTROL; SCORING SYSTEM; TISSUE MICROARRAY; TOTAL QUALITY MANAGEMENT; TRAINING; UNITED STATES; BREAST TUMOR; CLASSIFICATION; EDUCATION; FEMALE; HEALTH CARE QUALITY; HUMAN; METABOLISM; METHODOLOGY; MIDDLE AGED; OBSERVER VARIATION; PATHOLOGY; PROCEDURES; STANDARDS; STATISTICS AND NUMERICAL DATA; TEACHING;

BREAST NEOPLASMS; COMPUTER-ASSISTED INSTRUCTION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INTERNET; LABORATORIES; MIDDLE AGED; NIGERIA; OBSERVER VARIATION; PATHOLOGY; QUALITY ASSURANCE, HEALTH CARE; QUALITY IMPROVEMENT; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RESEARCH DESIGN; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL; UNITED STATES;

EID: 84887989106     PISSN: 10929134     EISSN: 15328198     Source Type: Journal    
DOI: 10.1016/j.anndiagpath.2013.07.003     Document Type: Article

References (26)

1. IARC P. Boyle, B. Levin, World Cancer Report 2008 IARC Press Lyon
2. I. Olofin, and O.I. Olopade Eliminating global disparities in breast cancer care through clinical research Am Soc Clin Oncol Ed Book 2009 681 684
3. P. Boyle Breast cancer control: signs of progress, but more work required Breast 14 6 2005 429 438
4. J. Kurebayashi, T. Moriya, and T. Ishida The prevalence of intrinsic subtypes and prognosis in breast cancer patients of different races Breast 16 Suppl. 2 2007 S72 S77
5. D.J. Blackman, and C.M. Masi Racial and ethnic disparities in breast cancer mortality: are we doing enough to address the root causes? J Clin Oncol 24 14 2006 2170 2178
6. O.I. Olopade, T.A. Grushko, and R. Nanda Advances in breast cancer: pathways to personalized medicine Clin Cancer Res 14 24 2008 7988 7999
7. J.S. Ross, W.F. Symmans, and L. Pusztai Standardizing slide-based assays in breast cancer: hormone receptors, HER2, and sentinel lymph nodes Clin Cancer Res 13 10 2007 2831 2835
8. N. Goldstein, S. Hewitt, and C. Taylor Recommendations for improved standardization of immunohistochemistry Appl Immunohistochem Mol Morphol 15 2 2007 124 133
9. A.M. Gown Current issues in ER and HER2 testing by IHC in breast cancer Mod Pathol 21 Suppl 2 2008 S8 S15
10. D. Huo, F. Ikpatt, and A. Khramtsov Population differences in breast cancer: survey in indigenous African women reveals over-representation of triple-negative breast cancer J Clin Oncol 27 2009 4515 4521
11. J. Kononen, L. Bubendorf, and A. Kallioniemi Tissue microarrays for high-throughput molecular profiling of tumor specimens Nat Med 4 1998 844 847
12. A. Reiner, B. Neumeister, and J. Spona Immunocytochemical localization of estrogen and progesterone receptor and prognosis in human primary breast cancer Cancer Res 50 21 1990 7057 7061
13. H. Battifora Assessment of antigen damage in immunohistochemistry. The vimentin internal control. Am J Clin Pathol 96 5 1991 669 671
14. A.C. Wolff, M.E. Hammond, and J.N. Schwartz American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer J Clin Oncol 25 1 2007 118 145
15. Interpretation Manual. Dako Inc.; http://www.dako.com/dist/index/ knowledgecenter/kc-publications/kc-publications-interpret/er-pr-pharmdx-.htm. last accessed 6/12/2013
16. S. Shousha Oestrogen receptor status of breast carcinoma: Allred/H score conversion table Histopathology 53 3 2008 346 347
17. A.C. Wolff, M.E. Hammond, and J.N. Schwartz American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer Arch Pathol Lab Med 131 1 2007 18 43
18. E. Ayad, and F. Sicurello Telepathology in emerging countries pilot project between Italy and Egypt Diagn Pathol 3 Suppl 1 2008 S2
19. C. Klock, and R. de P. Gomes Web conferencing systems: Skype and MSN in telepathology Diagn Pathol 3 Suppl 1 2008 S13
20. J.K. Mckenna, and S.R. Florell Cost-effective dynamic telepathology in the Mohs surgery laboratory utilizing iChat AV videoconferencing software Dermatol Surg 33 1 2007 62 68
21. J. Gilbertson, J. Ho, and L. Anthony Primary histologic diagnosis using automated whole slide imaging: a validation study BMC Clin Pathol 6 2006 4
22. C.K. Osborne Tamoxifen in the treatment of breast cancer N Engl J Med 339 1998 1609 1618
23. G.N. Hortobagyi Trastuzumab in the treatment of breast cancer N Engl J Med 353 2005 1734 1736
24. F. Hsu, T. Nielsen, and A. Alkushi Tissue microarrays are an effective quality assurance tool for diagnostic immunohistochemistry Mod Pathol 15 12 2002 1374 1380
25. M. Milanes-Yearsley, M.E. Hammond, and T.F. Pajak Tissue micro-array: a cost and time-effective method for correlative studies by regional and national cancer study groups Mod Pathol 15 12 2002 1366 1373
26. D. Seligson The tissue micro-array as a translational research tool for biomarker profiling and validation Biomarkers 10 Suppl. 1 2005 S77 S82